A carregar...
Inhibition of platelet function by abciximab or high-dose tirofiban in patients with STEMI undergoing primary PCI: a randomised trial
BACKGROUND: In patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI, few data exist on the magnitude of platelet activation, aggregation and dosing of glycoprotein (GP) IIb/IIIa receptor inhibitors. METHODS: Sixty STEMI patients were randomised to abciximab, to hig...
Na minha lista:
Main Authors: | , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Bohn Stafleu van Loghum
2007
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2082085/ https://ncbi.nlm.nih.gov/pubmed/18176639 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|